Ali Bhagat

Research Interest

• Medical device development
• Microfluidics
• Diagnostic development
• Cell separation technologies

Selected Awards & Honours

• 2017 – Innovative Biomedical Company of the Year by BioSingapore
• 2014 – Winner TiE Silicon Valley Top Start-up , USA
• 2012 – Asian Innovation Awards – Gold Prize The Wall Street Journal, in partnership with Credit Suisse 2012 Asian Innovation Awards
• 2012 – Asian Entrepreneurship Award
• 2009 – Outstanding PhD Dissertation Award, University of Cincinnati, OH, USA
• 2003 – PhD Graduate Scholarship, University of Cincinnati, OH, USA

Education

• Ph.D University of Cincinnati (2006 — 2009)
• MS University of Cincinnati (2003 — 2006)
• BE University of Madras (1999 — 2003)

Companies

• Senior Translational Manager National University of Singapore (2018)
• Associate Professor (Practice), Department of Biomedical Engineering National University of Singapore (2018)
• Principal Manager A*ccelerate Technologies Pte Ltd (2018)
• Principal Manager Exploit Technologies Pte Ltd (2018 — 2018)
• Chief Operating Officer Biolidics Limited (formerly known as Clearbridge BioMedics Pte Ltd) (2017 — 2018)
• Senior Technical Director Clearbridge BioMedics Pte Ltd (2016 — 2017)
• Technical Director Clearbridge BioMedics Pte Ltd (2012 — 2015)
• Principal Scientist Clearbridge BioMedics Pte Ltd (2011 — 2011)
• Research Scientist Singapore-MIT Alliance for Research & Technology (2011 — 2011)